Works matching IS 17762596 AND DT 2023 AND VI 18 AND IP 4

Results: 13

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 543, doi. 10.1007/s11523-023-00979-1
By:
- DeMichele, Angela;
- Robert, Nicholas;
- Chen, Connie;
- Kim, Sindy;
- Zhang, Zhe;
- Lu, Dongrui Ray;
- Aguilar, Kathleen M.;
- Wang, Yunfei;
- Li, Benjamin;
- Schneeweiss, Sebastian;
- Rassen, Jeremy A.;
- Gaffney, Michael;
- McRoy, Lynn
Publication type:
Article
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 585, doi. 10.1007/s11523-023-00976-4
By:
- Babey, Hélène;
- Jamme, Philippe;
- Curcio, Hubert;
- Assié, Jean Baptiste;
- Veillon, Remi;
- Doubre, Hélène;
- Pérol, Maurice;
- Guisier, Florian;
- Huchot, Eric;
- Decroisette, Chantal;
- Falchero, Lionel;
- Corre, Romain;
- Cortot, Alexis;
- Chouaïd, Christos;
- Descourt, Renaud
Publication type:
Article
Role of Underlying Liver Pathology in the Development of Immune-Related Hepatitis: A Case–Control Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 601, doi. 10.1007/s11523-023-00980-8
By:
- Storm, Erica M.;
- Makrakis, Dimitrios;
- Lin, Genevieve I.;
- Talukder, Rafee;
- Bakaloudi, Dimitra R.;
- Shah, Eshana E.;
- Liou, Iris W.;
- Hockenbery, David;
- Grivas, Petros;
- Khaki, Ali Raza
Publication type:
Article
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 559, doi. 10.1007/s11523-023-00978-2
By:
- Santoni, Matteo;
- Massari, Francesco;
- Myint, Zin W.;
- Iacovelli, Roberto;
- Pichler, Martin;
- Basso, Umberto;
- Kopecky, Jindrich;
- Kucharz, Jakub;
- Buti, Sebastiano;
- Rizzo, Mimma;
- Galli, Luca;
- Büttner, Thomas;
- De Giorgi, Ugo;
- Kanesvaran, Ravindran;
- Fiala, Ondřej;
- Grande, Enrique;
- Zucali, Paolo Andrea;
- Fornarini, Giuseppe;
- Bourlon, Maria T.;
- Scagliarini, Sarah
Publication type:
Article
Correction to: Relugolix: A Review in Advanced Prostate Cancer.
Published in:
2023
By:
- Shirley, Matt
Publication type:
Correction Notice
Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 625, doi. 10.1007/s11523-023-00981-7
By:
- Zheng, Nan;
- Zhang, Yimin;
- Zeng, Yue;
- Ma, Qiang;
- Zhang, Ruiguang;
- Zhao, Qian;
- Lu, Conghua;
- Tian, Jie;
- Wang, ZhiGuo;
- Tang, Huan;
- Luo, Nuo;
- Xiao, Hualiang;
- He, Yong;
- Wu, Fang;
- Li, Li
Publication type:
Article
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 505, doi. 10.1007/s11523-023-00975-5
By:
- Chiu, Chao-Hua;
- Lin, Meng-Chih;
- Wei, Yu-Feng;
- Chang, Gee-Chen;
- Su, Wu-Chou;
- Hsia, Te-Chun;
- Su, Jian;
- Wang, Anne Kuei-Fang;
- Jen, Min-Hua;
- Puri, Tarun;
- Shih, Jin-Yuan
Publication type:
Article
Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 611, doi. 10.1007/s11523-023-00974-6
By:
- Yen, Chih-Chieh;
- Yeh, Yu-Min;
- Huang, Hsuan-Yi;
- Ting, Yu-Lin;
- Fu, Pei-An;
- Lin, Tzu-Chien;
- Liu, I-Ting;
- Yen, Chia-Jui
Publication type:
Article
ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 571, doi. 10.1007/s11523-023-00973-7
By:
- Wang, Michelle;
- Slatter, Shadera;
- Sussell, Jesse;
- Lin, Chia-Wei;
- Ogale, Sarika;
- Datta, Debajyoti;
- Butte, Atul J.;
- Bazhenova, Lyudmila;
- Rudrapatna, Vivek A.
Publication type:
Article
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 593, doi. 10.1007/s11523-023-00972-8
By:
- Heseltine, Jonathan;
- Allison, Jennifer;
- Wong, Sam;
- Prasad, Kellati;
- Oong, Zhu-Chuen;
- Wong, Helen;
- Law, Andrea;
- Charnley, Natalie;
- Parikh, Omi;
- Waddell, Tom;
- Chow, Shien
Publication type:
Article
PARP Inhibitors in Ovarian Cancer: A Review.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 471, doi. 10.1007/s11523-023-00970-w
By:
- O'Malley, David M.;
- Krivak, Thomas C.;
- Kabil, Nashwa;
- Munley, Jiefen;
- Moore, Kathleen N.
Publication type:
Article
Cost-Effectiveness Analysis of Biomarker Testing to Guide First-Line PARP Inhibitor Maintenance for Patients with Advanced Ovarian Cancer After Response to First-Line Platinum Chemotherapy in the USA.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 531, doi. 10.1007/s11523-023-00966-6
By:
- Elsea, David;
- Muston, Dominic;
- Fan, Lin;
- Mihai, Adela;
- Meng, Yang;
- Kasle, Adam;
- Monberg, Matthew
Publication type:
Article
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Published in:
Targeted Oncology, 2023, v. 18, n. 4, p. 517, doi. 10.1007/s11523-023-00965-7
By:
- Bauer, Todd M.;
- Moore, Kathleen N.;
- Rader, Janet S.;
- Simpkins, Fiona;
- Mita, Alain C.;
- Beck, J. Thaddeus;
- Hart, Lowell;
- Chu, Quincy;
- Oza, Amit;
- Tinker, Anna V.;
- Imedio, Esteban Rodrigo;
- Kumar, Sanjeev;
- Mugundu, Ganesh;
- Jenkins, Suzanne;
- Chmielecki, Juliann;
- Jones, Suzanne;
- Spigel, David;
- Fu, Siqing
Publication type:
Article